NNPTE
KRTX

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-50,400
Closed -$16M – 40
2023
Q4 		$16M Buy
50,400
+9
+0% +$1.75K 3.63% 13
2023
Q3 		$8.52M Hold
50,391
– – 2.69% 15
2023
Q2 		$10.9M Buy
50,391
+3,015
+6% +$646K 3.17% 17
2023
Q1 		$8.61M Buy
47,376
+1,513
+3% +$289K 3.04% 14
2022
Q4 		$9.01M Buy
45,863
+1,720
+4% +$369K 3.92% 14
2022
Q3 		$9.93M Buy
+44,143
New +$8.93M 4.68% 11

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne's KRTX Position: Q1 2024 in Review

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 50,400 shares — an estimated $16M sold.

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne first reported a position in KRTX in Q3 2022 and held it in 6 quarters. The position peaked at $16M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Nationale-Nederlanden Powszechne Towarzystwo Emerytalne reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Nationale-Nederlanden Powszechne Towarzystwo Emerytalne sold 50,400 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $16M.
  • Nationale-Nederlanden Powszechne Towarzystwo Emerytalne first reported a position in Karuna Therapeutics, Inc. Common Stock in Q3 2022 and held it in 6 quarters.
  • Nationale-Nederlanden Powszechne Towarzystwo Emerytalne's Karuna Therapeutics, Inc. Common Stock position peaked at $16M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Nationale-Nederlanden Powszechne Towarzystwo Emerytalne's 13F filing for Q1 2024, filed 7 May 2024.